XML 21 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:        
Net loss $ (14,601,507) $ (5,482,793) $ (10,997,929) $ (5,845,053)
Adjustments to reconcile net loss to net cash used in operating activities:        
Depreciation and amortization 631,083 (76,013) 43,871 591,459
Stock-based compensation 1,664,191 593,116 865,112 1,329,643
Stock-based compensation - restricted common stock 33,333 33,332
Interest and accretion on convertible notes and notes payable 1,637,951 74,410 126,024
Issuance of common stock for services     237,500
Issuance of warrants for services 1,850,533 368,287 253,749
Change in fair value of contingent liabilities 2,131,000 (472,000) 1,387,000
Loss on debt extinguishment     663,522
Change in operating assets and liabilities:        
Accounts and other receivables (18,402) (55,706) 36,298 (40,585)
Prepaid expenses (582,649) 38,057 (184,112) 307,983
Inventory (228,834) 40,950 33,987 127,129
Deposits     (30,000)
Accounts payable and accrued expenses (740,034) 721,078 968,788 (155,661)
Due to related parties (1,009,368) 272,530 868,725
Net cash used in operating activities (9,266,036) (4,313,038) (5,787,095) (3,223,836)
Cash flows used in investing activities:        
Purchase of intangible assets     (148,656)
Net cash used in investing activities     (148,656)
Cash flows from financing activities:        
Proceeds from promissory notes, net of issuance cost 6,500,743 1,060,949 263,907
Proceeds from financing, net of issuance costs     6,692,765
Shares issued for cash, net of offering costs     6,275,164
Proceeds from promissory notes, due to related parties 366,000    
Repayment of notes payable (127,798)    
Proceeds from exercise of warrants 3,000    
Net cash provided by financing activities 6,375,945 1,426,949 6,956,672 6,275,164
Net change in cash (2,890,091) (2,886,089) 1,169,577 2,902,672
Cash at beginning of period 4,072,339 2,902,762 2,902,762 90
Cash at end of period 1,182,248 16,673 4,072,339 2,902,762
Supplemental disclosure of cash flow information:        
Cash paid for interest 45,449
Cash paid for taxes
Non-cash investing and financing activities:        
Derivative liabilities and debt discount issued in connection with convertible notes 2,438,379 391,648 2,485,346
Warrants and debt discount issued in connection with convertible notes 4,341,042 571,807 5,125,534
Settlement of notes payable with convertible notes 278,678    
Contingent liabilities $ 9,926,000 9,926,000
Issuance of common stock in lieu of payables     261,453
Issuance of common stock in connection with business combination     7,774,000 12,500,000
Notes payable assumed in connection with business combination     468,137
Issuance of warrants in connection with business combination     1,932,300
Initial adoption of ROU asset and lease liability     $ 1,317,830